Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMT-2: Peginterferon Lambda-1a in Chronic HDV
NCT05070364Phase 3Unknown
- Sponsor
- Eiger BioPharmaceuticals, Inc.
- Start
- Dec 2021
- Primary completion
- Jun 2024
- Modality
- Cytokines & Interferons
- Countries
- 12
01
Overview
A Phase 3 trial of peginterferon lambda-1a in hepatitis D (HDV), sponsored by Eiger BioPharmaceuticals, Inc.. Status: unknown.
02
Drugs
peginterferon lambda-1a
03
Conditions
hepatitis D (HDV)
Beyond the preview
Go deeper on NCT05070364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05070364.